| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | JNK Inhibitor VIII | GDSC1000 | pan-cancer | AAC | -0.099 | 0.007 |
| mRNA | LBW242 | CCLE | pan-cancer | AAC | -0.13 | 0.008 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | 0.14 | 0.008 |
| mRNA | QL-VIII-58 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.009 |
| mRNA | Bicalutamide | FIMM | pan-cancer | AAC | -0.42 | 0.01 |
| mRNA | navitoclax:pluripotin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.092 | 0.01 |
| mRNA | SID 26681509 | CTRPv2 | pan-cancer | AAC | -0.097 | 0.01 |
| mRNA | LFM-A13 | GDSC1000 | pan-cancer | AAC | -0.094 | 0.01 |
| mRNA | Gemcitabine | GDSC1000 | pan-cancer | AAC | 0.094 | 0.01 |
| mRNA | Mitomycin-C | GDSC1000 | pan-cancer | AAC | 0.095 | 0.01 |